bromocriptine has been researched along with Alloxan Diabetes in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El Latif, HA; El Yamani, M; Fouad Shalaby, MA; Galal, MA; Kamal, S; Masaood, R; Sindi, I | 1 |
| Bondareva, VM; Chistyakova, OV; Derkach, KV; Shpakov, AO | 1 |
| Bondareva, VM; Derkach, KV; Moyseyuk, IV; Shpakov, AO | 1 |
| Kolta, MG; Kuperberg, JM; Ngong, JM; Rutledge, LP; Samaan, SS; Soliman, KF | 1 |
| Bondareva, VM; Guryanov, IA; Kuznetsova, LA; Pertseva, MN; Plesneva, SA; Shpakov, AO; Vlasov, GP | 1 |
| Endo, T; Hara, S; Iwata, N; Mukai, T; Nishimura, C; Takahashi, M; Takayama, M | 1 |
| Alves, V; Coulaud, J; Dardenne, M; Durant, S; El Hasnaoui, A; Homo-Delarche, F | 1 |
| Holstad, M; Sandler, S | 1 |
| Baxter, MA; Coore, HG; Goheer, MA | 1 |
| Dupré, J; Garcia, B; Gibson, C; Gunn, HC; Mahon, JL; Stiller, CR; Stobie, K | 1 |
| Careche, M; García-Ruíz, JP; Lobato, MF; Moreno, FJ; Ros, M | 1 |
11 other study(ies) available for bromocriptine and Alloxan Diabetes
| Article | Year |
|---|---|
Therapeutic activity of sarpogrelate and dopamine D
Topics: Animals; Blood Glucose; Bromocriptine; Cabergoline; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dopamine Agonists; Drug Therapy, Combination; Isoenzymes; Kidney; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardium; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Succinates; Troponin I; Tumor Necrosis Factor-alpha | 2021 |
The influence of bromocryptine treatment on activity of the adenylyl cyclase system in the brain of rats with type 2 diabetes mellitus induced by high-fat diet.
Topics: Adenylyl Cyclases; Animals; Blood Glucose; Body Weight; Brain; Bromocriptine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dopamine; Hypoglycemic Agents; Male; Norepinephrine; Rats, Wistar; Receptors, Dopamine D2; Relaxin; Serotonin; Somatostatin | 2014 |
[The influence of two-month treatment with bromocryptine on activity of the adenylyl cyclase signaling system in the myocardium and testes of rats with type 2 diabetes mellitus].
Topics: Adenylyl Cyclases; Administration, Oral; Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dioxoles; Dopamine Agonists; Drug Administration Schedule; Ethanolamines; Guanylyl Imidodiphosphate; Humans; Insulin Resistance; Isoproterenol; Male; Myocardium; Norepinephrine; Rats; Rats, Wistar; Relaxin; Signal Transduction; Streptozocin; Testis; Triglycerides | 2014 |
Dopaminergic system modulation of nociceptive response in long-term diabetic rats.
Topics: Animals; Behavior, Animal; Blood Glucose; Brain Chemistry; Bromocriptine; Diabetes Mellitus, Experimental; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enkephalin, Methionine; Haloperidol; Hypoglycemic Agents; Insulin; Male; Nociceptors; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Spinal Cord; Time Factors; Tissue Distribution | 2002 |
Decrease in functional activity of G-proteins hormone-sensitive adenylate cyclase signaling system, during experimental type II diabetes mellitus.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Bromocriptine; Cardiotonic Agents; Colforsin; Corpus Striatum; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Activation; GTP-Binding Proteins; Hormone Antagonists; Hormones; Isoproterenol; Myocardium; Peptides; Rats; Rats, Wistar; Relaxin; Serotonin; Serotonin Agents; Signal Transduction; Somatostatin | 2006 |
Hormonal regulation of aldose reductase in rat ovary during the estrous cycle.
Topics: Aldehyde Reductase; Animals; Bromocriptine; Chlorpromazine; Chorionic Gonadotropin; Diabetes Mellitus, Experimental; Estradiol; Estrus; Female; Hormone Antagonists; Hormones; Immunohistochemistry; Ovary; Pituitary Hormones; Rats; Rats, Inbred WKY; RNA, Messenger; Testosterone | 1996 |
Attempts to pharmacologically modulate prolactin levels and type 1 autoimmune diabetes in the non-obese diabetic (NOD) mouse.
Topics: Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dopamine Agonists; Dopamine Antagonists; Female; Islets of Langerhans; Male; Metoclopramide; Mice; Mice, Inbred NOD; Prolactin; Treatment Outcome | 1995 |
Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice.
Topics: Animals; Autoimmune Diseases; Blood Glucose; Bromocriptine; Diabetes Mellitus, Experimental; Dopamine Agonists; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Prolactin; Streptozocin | 1999 |
Effects of starvation, diabetes and 2-bromo-alpha-ergocryptine treatment on pyruvate dehydrogenase activity in lactating rat mammary gland.
Topics: Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus, Experimental; Female; Lactation; Mammary Glands, Animal; Mitochondria; Phosphorylation; Pregnancy; Protein Kinases; Pyruvate Dehydrogenase (Lipoamide)-Phosphatase; Pyruvate Dehydrogenase Complex; Rats; Starvation | 1978 |
The effect of bromocriptine and cyclosporine on spontaneous diabetes in BB rats.
Topics: Animals; Autoimmune Diseases; Bromocriptine; Cyclosporins; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Drug Therapy, Combination; Prolactin; Rats; Rats, Inbred Strains | 1988 |
Effect of prolactin and glucocorticoids on P-enolpyruvate carboxykinase activity in liver and mammary gland from diabetic and lactating rats.
Topics: Adrenal Glands; Animals; Bromocriptine; Diabetes Mellitus, Experimental; Enzyme Activation; Enzyme Induction; Female; Glucocorticoids; Gluconeogenesis; Lactation; Liver; Mammary Glands, Animal; Phosphoenolpyruvate Carboxykinase (GTP); Pregnancy; Prolactin; Rats; Rats, Inbred Strains | 1985 |